Literature DB >> 3259931

Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonists.

A R Braun1, T N Chase.   

Abstract

Chronic treatment with the selective D-1 agonist SKF 38393 induced behavioral supersensitivity (increased stereotypy and decreased locomotor activity) in response to apomorphine, In contrast, chronic treatment with the selective D-2 agonist LY 171555 resulted in a subsensitive behavioral response to apomorphine challenge. Chronic treatment with the combination of these drugs augmented apomorphine-induced stereotypic behaviors, but these were different in nature from those observed in animals treated with SKF 38393 alone. Chronic SKF 38393 treatment resulted in an enhanced behavioral response to SKF 38393 itself. Behavioral response to LY 171555 was affected only by chronic treatment with the combination of selective agonists. These results suggest that chronic D-1 receptor stimulation may be necessary and sufficient for the development of dopamine agonist-induced behavioral sensitization in the intact rat; the mechanism may involve increased sensitivity of D-1 receptor-associated mechanisms. Chronic D-2 receptor stimulation appears to have the opposite effect. These results also provide evidence that a synergistic interaction between receptor subtypes may underlie certain behavioral effects of chronic agonist exposure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259931     DOI: 10.1016/0014-2999(88)90179-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine.

Authors:  B A Mattingly; J K Rowlett; J T Graff; B J Hatton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Repeated SKF 38393 and nigrostriatal system neuronal responsiveness: functional down-regulation is followed by up-regulation after withdrawal.

Authors:  M D Kelland; D K Pitts; A S Freeman; L A Chiodo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

Review 3.  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

Authors:  A R Braun; M Laruelle; M M Mouradian
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Sensitivity to apomorphine-induced yawning and hypothermia in rats eating standard or high-fat chow.

Authors:  Michelle G Baladi; Yvonne M Thomas; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2011-12-30       Impact factor: 4.530

5.  Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin.

Authors:  D C Hoffman; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice.

Authors:  J B Bedingfield; L D Calder; R Karler
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

7.  Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.

Authors:  Y Hatta; S Hatta; T Saito
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.

Authors:  H Lublin; J Gerlach; L Peacock
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Electroconvulsive treatment attenuates behavioral response to SKF 38393 in reserpine-treated mice.

Authors:  X Z Hao; A A Mathé; J M Mathé; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.

Authors:  B A Mattingly; J K Rowlett; G Lovell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.